GGrantIndex
Sort

51,593 grants matching hepatitis

Characterization of Mucosal Lymphocytes

$675,717
Richard S Blumberg · Brigham And Women'S Hospital · R37 · FY2007 · DK

GENERATION/EMERGENCE OF VARIANT IN HEPADNAVIRUS INFECTON

$675,689
University Of New Mexico · R01 · FY2003 · CA

Toll-like receptor control of endocytic antigen cross-presentation

$675,627
Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI

Toll-like receptor control of endocytic antigen cross-presentation

$675,627
Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI

Toll-like receptor control of endocytic antigen cross-presentation

$675,627
Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

Quantitative studies of metabolic organ dynamics

$675,540
Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2019 · DK

Clinical

$675,535
Rajesh T Gandhi · Harvard University · P30 · FY2010 · AI

Interactions Between Diverse Brain Cell Types Drive Aicardi-Goutieres Neuropathology

$675,062
Mariko L. Bennett · Children'S Hosp Of Philadelphia · R01 · FY2025 · NS

Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention

$674,980
Shirish S Barve · University Of Louisville · R01 · FY2024 · AA

Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention

$674,840
Brian R. Edlin · National Development And Research Institutes, Inc. · R01 · FY2014 · DA

Development of a PAL PKU Enzyme Subsitution Therapy

$674,604
Raymond C Stevens · Scripps Research Institute, The · U01 · FY2006 · NS

Prolonged Daily Fasting As a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

$674,558
Lisa Senye Chow · University Of Minnesota · R01 · FY2022 · DK

Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)

$674,545
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK

Mycobacterium tuberculosis antigen diversity

$674,536
Joel D. Ernst · New York University School Of Medicine · R01 · FY2011 · AI

Quantification of Liver Fibrosis with MRI and Deep Learning

$674,452
Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · EB

Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus

$674,441
Benjamin Doranz · Integral Molecular · N01 · FY2017 · AI

Structurally dissecting APOBEC3's for HIV-1 restriction and beyond

$674,415
Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI

Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors

$674,412
Wendy Landier · University Of Alabama At Birmingham · R01 · FY2016 · CA

SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis

$674,244
Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2023 · DK

SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis

$674,244
Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2025 · DK

Cytochrome P-450 Polymorphism

$674,233
Eric F Johnson · Scripps Research Institute, The · R01 · FY2007 · GM

Impact of the 340B Drug Pricing Program on Medication Utilization, Health Outcomes, and Disparities in Medicare

$674,227
Sunita Desai · New York University School Of Medicine · R01 · FY2025 · AG

PROTEOMICS CORE

$674,198
Richard Daniel Carliss · University Of Washington · P30 · FY2009 · DA

Women's Risk Networks: Resources, Infection and Change

$674,132
Columbia University Health Sciences · R01 · FY2004 · DA

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles

$674,097
Yazhen Zhu · University Of California Los Angeles · R01 · FY2023 · CA